Navigation Links
Global Rheumatoid Arthritis Drugs Market 2014-2018

DUBLIN, July 28, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Rheumatoid Arthritis Drugs Market 2014-2018" report to their offering.

RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation of the tissues that surround the joints and in other organs.

The symptoms of RA begin slowly, usually just mild pain around the joints coupled with stiffness and fatigue, and in the later stages it causes inflammation of the joints. It can occur at any age, even in children, which is called juvenile arthritis. The disease is three times more common in women than in men. Genetic and environmental elements are known to contribute in the development of RA.

The analysts forecast the Global Rheumatoid Arthritis Drugs market will grow at a CAGR of 4.09 percent over the period 2013-2018.

Key Topics Covered:

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

04. Market Research Methodology

05. Introduction

06. Market Landscape

07. Competitive Assessment of Top Drugs

08. Five Forces Analysis

09. Market Segmentation by Category

10. Geographical Segmentation

11. Buying Criteria

12. Rate of Incidence and Prevalence

13. Pipeline Snapshot

14. Market Growth Drivers

15. Drivers and their Impact

16. Market Challenges

17. Impact of Drivers and Challenges

18. Market Trends

19. Trends and their Impact

20. Vendor Landscape

21. Key Vendor Analysis

22. Other Reports in this Series

Companies Mentioned:

  • AbbVie Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.
  • AB Science SA
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Biogen Idec Inc.
  • Boehringer Ingelheim GmbH
  • Celgene Corp.
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly & Co.
  • GE Healthcare Co.
  • Genmab A/S
  • GSK plc
  • Incyte Corp.
  • Merck & Co. Inc.
  • Mitsubishi Tanabe Pharma Corp.
  • Novartis AG
  • Novo Nordisk A/S
  • Rigel Pharmaceuticals Inc.
  • Sanofi
  • Takeda Pharmaceutical Co. Ltd.
  • UCB SA
  • Vertex Pharmaceuticals Inc.

For more information visit

Media Contact: Laura Wood, +353-1-481-1716,

SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Global and Chinese Vardenafil Industry (CAS 224785-90-4) 2019 Forecasts
2. Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development
3. Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research
4. Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon
5. Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019
6. Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020
7. Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical
8. Prepackaged Medical Kits and Trays - Global Strategic Business Report: Updated 2014 Report
9. Emulsifiers - Global Strategic Business Report: Updated 2014 Report
10. Global Digital X-Ray Market 2018 Analysis and Forecast In New Research Report Available at
11. Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018
Post Your Comments:
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the European ... system called the HORIZON at MIBio 2017 in Cambridge, ... and visible particulate matter in biopharmaceutical samples with unprecedented speed and ... the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology:
(Date:10/13/2017)... CT (PRWEB) , ... October 13, 2017 , ... ... long-term care services, staged a mock evacuation of the facility as part of a ... Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as ...
(Date:10/13/2017)... Texas (PRWEB) , ... October 13, 2017 , ... Yisrayl ... this week that explains one of the most popular and least understood books in ... like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have tossed ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... healthcare compliance program management, will showcase a range of technology and learning solutions ... Living (NCAL) Convention and Expo to be held October 14–18, 2017 at the ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at ... for the 49th Congress of the International Society of Paediatric Oncology (SIOP) ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. ...
Breaking Medicine News(10 mins):